Tourette Syndrome: Pathophysiology, Neurochemical Basis, Comorbid Psychiatric Conditions, and Current Management
Year: 2026
Type: article
Abstract: Tourette syndrome is a childhood-onset neurodevelopmental disorder characterized by involuntary motor and vocal tics, arising from complex interactions between genetic predisposition and dysregulation of dopaminergic, glutamatergic, GABAergic, serotonergic, histaminergic, and noradrenergic neurotransmitter systems within cortico-striato-thalamo-cortical circuits. Symptoms typically emerge between four and six years of age, peak in severity around ten to twelve years, and often remit by early adulthood, though many patients continue experiencing persistent symptoms. The disorder is frequently accompanied by neuropsychiatric comorbidities, particularly attention deficit hyperactivity disorder and obsessive compulsive disorder, which substantially affect quality of life. This review summarizes current understanding of epidemiology, neurobiology, differential diagnosis, and management strategies, emphasizing behavioral interventions as first-line treatment, with pharmacological and surgical options reserved for refractory cases.
Language: English
Subfield: Clinical Psychology
Field: Psychology
Domain: Social Sciences
Keywords: Tourette syndrome, tics, pathophysiology, neurotransmitter systems, cortico-striato-thalamo-cortical circuit, neuropsychiatric comorbidity, attention deficit hyperactivity disorder, obsessive-compulsive disorder, behavioral interventions, pharmacotherapy, surgical treatment, genetic susceptibility, differential diagnosis
Open Access status: diamond
OpenAlex ID: W7215382312
